Fouremm,

The question imo, will  1 or many BP get very  excited about owning this epigenetic technology at some point in this next few years as the trials progress to registration enabling  and approval , At that point if the Buyout price is less than Constellation of $1.7 Billion than management is fully patheitc and incompetant , These $1USd private placing are pathetic but does it matter if the end game is a buyout, maybe no IPO is in the plaans.  I get these spidey feeling that DM would lieke to go up against BP's if the FDA approves Zen3694 for clinical trials ongoing  . there maybe some spite after all these years of no major deals , just a guess , hope i am  wrong and he take any deal that properly valuates this technology.